Current Psychiatry Reports

, Volume 5, Issue 6, pp 419–422

False beliefs: The current treatment of patients with depression

  • Yves Lecrubier
Invited Commentary
  • 55 Downloads

Conclusions

All of these false beliefs may be related to the stigma associated with psychiatry; however, each of them is, in fact, a strong “theory,” independent but networking with the others. Each of these beliefs needs a specific educational campaign or should be addressed during medical studies. Very large studies realized in daily life practice populations with long-term follow-up are badly needed.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldberg DP, Lecrubier Y: Form and frequency of mental disorders across centres. In Mental Illness in General Health Care: An International Study. Edited by Ustun TB, Sartorius N. Chichester, UK: Wiley Press; 1995:323–334.Google Scholar
  2. 2.
    Lecrubier Y: Is depression under-recognized and undertreated? Int Clin Psychopharmacol 1998, 13:3–6.CrossRefGoogle Scholar
  3. 3.
    Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8–19.PubMedGoogle Scholar
  4. 4.
    Wittchen HU, Lieb R, Wunderlich U, Schuster P: Comorbidity in primary care: presentation and consequences. J Clin Psychiatry 1999, 60:29–36.PubMedCrossRefGoogle Scholar
  5. 5.
    Blazer DG, Kessler RC, McGoagle KA, Swartz MS: The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994, 151:979–986.PubMedGoogle Scholar
  6. 6.
    Wells KB, Stewart A, Hays RD: The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989, 262:914–919.PubMedCrossRefGoogle Scholar
  7. 7.
    Ormel J, Von Korff M, Ustun TB, et al.: Common mental disorders and disability across cultures. JAMA 1994, 272:1741–1748.PubMedCrossRefGoogle Scholar
  8. 8.
    Kessler RC, Zhao S, Blazer DG, Swartz M: Prevalence, correlates and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997, 45:19–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause, 1990 to 2020: global burden of disease study. Lancet 1997, 349:1498–1504.PubMedCrossRefGoogle Scholar
  10. 10.
    Lecrubier Y, Weiller E: New treatment strategies in generalized anxiety disorder. Eur Neuropsychopharmacol 2000, 10:170–172.CrossRefGoogle Scholar
  11. 11.
    Lecrubier Y: Depressive illness and disability. Eur Neuropsychopharmacol 2000, 10:439–443.CrossRefGoogle Scholar
  12. 12.
    Simon G, Lecrubier Y, Ustun TB: Somatic symptoms and psychiatric disorder: an international primary care study. Rev Contemp Pharmacother 1996, 7:279–285.Google Scholar
  13. 13.
    Beautrais A, Joyce P, Mulder R, et al.: Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatr 1996, 153:1009–1014.PubMedGoogle Scholar
  14. 14.
    Angst F, Stassen HH, Clayton PJ, et al.: Mortality of patients with mood disorders: follow up over 34 to 38 years. J Affect Disord 2002, 68:167–181.PubMedCrossRefGoogle Scholar
  15. 15.
    Kirmayer LJ, Robbins JM, Dworkin M: Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993, 150:734–741.PubMedGoogle Scholar
  16. 16.
    Clearly P, Guy W: Factor analysis of the Hamilton Depression Scale. Drugs Exp Clin Res 1977, 1:115–120.Google Scholar
  17. 17.
    Ohishi M, Kamijima K: A comparison of characteristics of depressed patients and efficacy of sertraline and amitriptyline between Japan and the West. J Affect Disord 2002, 70:165–173.PubMedCrossRefGoogle Scholar
  18. 18.
    Angst J: Epidemiology of depression. Psychopharmacology 1992, 106:71–74.CrossRefGoogle Scholar
  19. 19.
    Frank E, Kupfer D, Perel J, et al.: Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990, 47:1093–1099.PubMedGoogle Scholar
  20. 20.
    Simon GE, Von Korff M, Piccinelli M, et al.: An international study of the relation between somatic symptoms and depression. N Engl J Med 1999, 341:1329–1335.PubMedCrossRefGoogle Scholar
  21. 21.
    Dworkin S, VonKorff M, Leresche L: Multiple pains and psychiatric disturbance: an epidemiologic investigation. Arch Gen Psychiatry 1990, 47:239–244.PubMedGoogle Scholar
  22. 22.
    Kroenke K, Spitzer RL, Williams JBW, et al.: Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994, 3:774–779.PubMedCrossRefGoogle Scholar
  23. 23.
    Hein S, Bonsignore M, Berkow K, et al.: Lifetime depressive and somatic symptoms as preclinical markers of late-onset depression. Eur Arch Psychiatry Clin Neurosci 2003, 253:16–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Horwath E, Johnson J, Klerman GL, Weissman MM: Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 1992, 49:817–823.PubMedGoogle Scholar
  25. 25.
    Judd LL, Akiskal HS, Maser JD, et al.: Major depressive disorder symptoms as predictor of rapid relapse. J Affect Disord 1998, 50:97–108.PubMedCrossRefGoogle Scholar
  26. 26.
    Fava GA, Grandi S, Zielezny M, et al.: Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994, 151:1295–1299.PubMedGoogle Scholar
  27. 27.
    Paykel ES, Ramana R, Cooper Z, et al.: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995, 25:1171–1180.PubMedCrossRefGoogle Scholar
  28. 28.
    Regier DA, Rae DS, Narrow WE, et al.: Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Brit J Psychiatry 1998, 173:24–28.Google Scholar
  29. 29.
    Rutz W, Carlsson P, Von Knorring L, Walinder J: Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiat Scand 1992, 85:457–464.PubMedGoogle Scholar
  30. 30.
    Rihmer Z, Rutz W, Barsi J: Suicide rate, prevalence of diagnosed depression and prevalence of working physicians in Hungary. Acta Psychiatr Scand 1993, 88:391–394.PubMedGoogle Scholar
  31. 31.
    Isacsson G, Bergman U, Rich CL: Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996, 41:1–8.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • Yves Lecrubier
    • 1
  1. 1.Unité Inserm 302Hôpital de la SalpétrièreParis Cedex 13France

Personalised recommendations